TBA-354
TBA-354 is a novel antitubercular agent that shows MIC of 6 uM against M. tuberculosis H37Rv; maintains activity against Mycobacterium tuberculosis H37Rv isogenic monoresistant strains and clinical drug-sensitive and drug-resistant isolates, demonstrates superior potency and pharmacokinetic profile compared with PA-824, 5 to 10 times more potent than PA-824.Bacterial Infection Phase 1 Clinical.
Product Specifications
CAS Number
1257426-19-9
Product Name Alternative
TBA354
Purity
>98% (HPLC)
Solubility
DMSO: ≥ 46 mg/mL
Smiles
O=[N+] (C1=CN2C (OC[C@@H] (OCC3=CC=C (C4=CC=C (OC (F) (F) F) C=C4) N=C3) C2) =N1) [O-]
Molecular Formula
C19H15F3N4O5
Molecular Weight
436.3414
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
5H-Imidazo[2,1-b][1,3]oxazine, 6,7-dihydro-2-nitro-6-[[6-[4- (trifluoromethoxy) phenyl]-3-pyridinyl]methoxy]-, (6S) -
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog